Pharmaceutical giant Amgen is exempting providers in Utah, North Dakota and South Dakota from its 340B restrictions after those states [...] …
Category: Pharma Industry
The U.S. Department of Health and Human Services (HHS) plans to release guidance within 30 days on 340B rebate models [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Both chambers of the Hawaii Legislature yesterday approved a 340B contract pharmacy access bill with provider reporting requirements following weeks [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major drug manufacturers are loosening their 340B contract pharmacy restrictions for states that have passed contract pharmacy access laws [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge today in Washington, D.C. scrutinized arguments from both manufacturers and the government in a closely watched hearing [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge in Washington, D.C., is holding high-stakes hearings today on five drug industry lawsuits challenging the government’s opposition [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Recent Health Resources and Services Administration (HRSA) audits found that two drugmakers overcharged covered entities for their 340B drugs, fueling [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
State legislators in California, Texas and Oklahoma have recently advanced 340B contract pharmacy access bills with amendments that in some [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...] …